Luzelena Caro

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Low Density Lipoprotein

Hepatitis C Virus

Clinical Evaluation

Human Immunodeficiency Virus

Top Venues

Hepatology communications

Antimicrobial agents and chemotherapy

Clinical drug investigation

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Olena Anoshchenko, Mazin Abdelghany, Amos Lichtman, Ran Duan, Henry Chen, Naveed A Shaik, Chi-Chi Peng, Qin Yue, Raju Subramanian, Robert H Hyland, Santosh Davies, Keelin Castellanos, Lily Mak, Gong Shen, Deqing Xiao, Luzelena Caro, Helen Winter, Joe Llewellyn, Rita Humeniuk
Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants. Clinical pharmacology and therapeutics (2024)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Regino P Gonzalez-Peralta, Stefan Wirth, Robert H Squires, Frauke Mutschler, Thomas Lang, Małgorzata Pawłowska, Wojciech Sluzewski, Ewa Majda-Stanisławska, Bjorn Fischler, William F Balistreri, Maureen M Jonas, Niviann Blondet, Philip Rosenthal, Rohit L Loomba, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I S Rosenbloom, Barbara A Haber
Elbasvir/grazoprevir in children aged 3-18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study. Hepatology communications 7 (3) (2023)
Luzelena Caro, Thomayant Prueksaritanont, Christine M Fandozzi, Hwa-Ping Feng, Zifang Guo, Dennis Wolford, Deborah Panebianco, Iain P Fraser, Vanessa Levine, Dennis Swearingen, Joan R Butterton, Marian Iwamoto, Wendy W Yeh
Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults. Clinical drug investigation 41 (2) (2021)
Kajal B Larson, Yogesh T Patel, Susan Willavize, John S Bradley, Elizabeth G Rhee, Luzelena Caro, Matthew L Rizk
Ceftolozane-Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients with Complicated Urinary Tract or Complicated Intra-abdominal Infections. Antimicrobial agents and chemotherapy 63 (6) (2019)
Hwa-Ping Feng, Luzelena Caro, Christine Fandozzi, Xiaoyan Chu, Zifang Guo, Jennifer Talaty, Deborah Panebianco, Katherine Dunnington, Lihong Du, William D Hanley, Iain P Fraser, Anna Mitselos, Jean-Francois Denef, Inge De Lepeleire, Jan N de Hoon, Corinne Vandermeulen, William L Marshall, Patricia Jumes, Xiaobi Huang, Monika Martinho, Robert Valesky, Joan R Butterton, Marian Iwamoto, Wendy W Yeh
Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers. Antimicrobial agents and chemotherapy 63 (4) (2019)